Home/Filings/4/0001178913-23-003156
4//SEC Filing

Toledano Miranda Jayne 4

Accession 0001178913-23-003156

CIK 0001638097other

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 5:02 PM ET

Size

5.8 KB

Accession

0001178913-23-003156

Insider Transaction Report

Form 4
Period: 2023-09-13
Toledano Miranda Jayne
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-09-13+350,000350,000 total
    Exercise: $0.80Exp: 2033-04-24Ordinary Shares, par value NIS 0.0000769 per share (350,000 underlying)
Footnotes (1)
  • [F1]This grant of options was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on April 24, 2023, subject to approval by the Company's shareholders, which was obtained on September 13, 2023. The options vest over a four-year period that commenced on April 24, 2023, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.

Documents

1 file

Issuer

Entera Bio Ltd.

CIK 0001638097

Entity typeother

Related Parties

1
  • filerCIK 0001686530

Filing Metadata

Form type
4
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 5:02 PM ET
Size
5.8 KB